Alexander L. Weis
Vorstandsvorsitzender bei ONCOVISTA INNOVATIVE THERAPIES, INC.
Aktive Positionen von Alexander L. Weis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ONCOVISTA INNOVATIVE THERAPIES, INC. | Comptroller/Controller/Auditor | 16.08.2007 | - |
Vorstandsvorsitzender | 16.08.2007 | - | |
Finanzdirektor/CFO | 01.08.2009 | - | |
Präsident | 16.08.2007 | - | |
Vorsitzender | 16.08.2007 | - | |
Unternehmenssekretär | 16.08.2007 | - | |
Alere Diagnostics GmbH
Alere Diagnostics GmbH Medical SpecialtiesHealth Technology Alere Diagnostics GmbH develops diagnostics to detect circulating tumor cells in tumor patients. The company's tumor diagnostics are kits consisting of reagents for immunomagnetic selection, mRNA isolation and multiplex RT-PCR and can be performed on standard technology platforms. The products have analytical sensitivity (2 cells in 5 ml blood) and specificity (greater 90%) achieved through the combination of multi-marker tumor cell enrichment and multiplex gene expression profiling for treatment of cancer. The company was founded in 1999 and is headquartered in Langenhagen, Germany. | Vorstandsvorsitzender | 01.02.2009 | - |
Vorsitzender | 01.02.2009 | - | |
OncoVista-Sub | Vorstandsvorsitzender | - | - |
Vorsitzender | 01.09.2004 | - | |
Gründer | 01.09.2004 | - | |
Präsident | 01.09.2004 | - |
Karriereverlauf von Alexander L. Weis
Ehemalige bekannte Positionen von Alexander L. Weis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Aviation Upgrade Technologies, Inc. | Präsident | - | 14.01.2008 |
OncoVista, Inc.
OncoVista, Inc. Electronic Equipment/InstrumentsElectronic Technology OncoVista, Inc. develops cancer treatment technology. The firm provides drug discovery technologies, clinical development and registration strategies solutions. The company was founded in 2004 and is located in San Antonio, TX. | Präsident | - | 14.01.2008 |
Lipitek International, Inc. | Gründer | 01.01.1989 | 01.09.2004 |
Präsident | 01.01.1989 | 01.09.2004 | |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1994 | 01.01.1998 |
Gründer | 01.01.1994 | 01.01.1998 | |
Sterling Drug, Inc. | Corporate Officer/Principal | - | - |
EASTMAN KODAK COMPANY | Corporate Officer/Principal | - | - |
░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Alexander L. Weis
N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Deutschland | 2 |
Israel | 2 |
Operativ
President | 5 |
Chief Executive Officer | 3 |
Chairman | 3 |
Sektoral
Health Technology | 4 |
Producer Manufacturing | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
EASTMAN KODAK COMPANY | Producer Manufacturing |
ONCOVISTA INNOVATIVE THERAPIES, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Alere Diagnostics GmbH
Alere Diagnostics GmbH Medical SpecialtiesHealth Technology Alere Diagnostics GmbH develops diagnostics to detect circulating tumor cells in tumor patients. The company's tumor diagnostics are kits consisting of reagents for immunomagnetic selection, mRNA isolation and multiplex RT-PCR and can be performed on standard technology platforms. The products have analytical sensitivity (2 cells in 5 ml blood) and specificity (greater 90%) achieved through the combination of multi-marker tumor cell enrichment and multiplex gene expression profiling for treatment of cancer. The company was founded in 1999 and is headquartered in Langenhagen, Germany. | Health Technology |
Aviation Upgrade Technologies, Inc. | Producer Manufacturing |
OncoVista, Inc.
OncoVista, Inc. Electronic Equipment/InstrumentsElectronic Technology OncoVista, Inc. develops cancer treatment technology. The firm provides drug discovery technologies, clinical development and registration strategies solutions. The company was founded in 2004 and is located in San Antonio, TX. | Electronic Technology |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Health Technology |
Sterling Drug, Inc. | Consumer Non-Durables |
Lipitek International, Inc. | |
OncoVista-Sub |
- Börse
- Insiders
- Alexander L. Weis
- Erfahrung